Nano-X Imaging Ltd. (NNOX)
Market Cap | 395.61M |
Revenue (ttm) | 10.68M |
Net Income (ttm) | -49.70M |
Shares Out | 58.52M |
EPS (ttm) | -0.86 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,990,740 |
Open | 6.49 |
Previous Close | 6.57 |
Day's Range | 6.49 - 6.92 |
52-Week Range | 5.26 - 14.28 |
Beta | 2.01 |
Analysts | Buy |
Price Target | 12.00 (+77.52%) |
Earnings Date | Nov 21, 2024 |
About NNOX
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a ... [Read more]
Financial Performance
In 2023, Nano-X Imaging's revenue was $9.91 million, an increase of 15.47% compared to the previous year's $8.58 million. Losses were -$60.78 million, -46.33% less than in 2022.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for NNOX stock is "Buy" and the 12-month stock price forecast is $12.0.
News
Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication
PETACH TIKVA, Israel, Dec. 05, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has recei...
Nano-X Imaging Ltd. (NNOX) Q3 2024 Earnings Call Transcript
Nano-X Imaging Ltd. (NASDAQ:NNOX) Q3 2024 Earnings Conference Call November 21, 2024 8:30 AM ET Company Participants Mike Cavanaugh - IR Erez Meltzer - CEO Ran Daniel - CFO Conference Call Participan...
Nanox to Report Third Quarter and Financial Results on November 21, 2024
PETACH TIKVA, Israel, Nov. 11, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will repo...
Nanox Highlighted on TIME's Best Inventions of 2024 List for its AI Solutions
Nanox AI's Solutions selected for Special Mention on annual list recognizing the most impactful new products and ideas
Nanox to Participate in Upcoming Investor Conference in September 2024
PETACH TIKVA, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that Company man...
Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium
HealthCCSng V2.0 i ntroduces additional ‘ zero calcium ' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC d etection c ategory output
Nano-X Imaging Ltd. (NNOX) Q2 2024 Earnings Call Transcript
Nano-X Imaging Ltd. (NASDAQ:NNOX) Q2 2024 Earnings Conference Call August 20, 2024 8:30 AM ET Company Participants Mike Cavanaugh - IR Erez Meltzer - CEO Ran Daniel - CFO Conference Call Participants...
Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
Accelerated the deployment of Nanox ARC in the US market, Submitted a new 510k application to the FDA to expand Nanox.ARC indications to include general use, including chest Nanox.AI Receives FDA 51...
Nanox to Report Second Quarter and Financial Results on August 20, 2024
PETACH TIKVA, Israel, Aug. 06, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will repo...
Innovative Data Featuring Nanox AI Cardiac Solution Showcased at SCCT 2024
In a study conducted by Brigham & Women's Hospital, Nanox.AI-Based Analysis helps Reveal Coronary Artery Calcium in over 50% of IMID Patients; Lead author Brittany Weber, MD, PhD, declared as ‘Young I...
Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of Cardiovascular Computed Tomography
PETACH TIKVA, Israel, June 25, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that data from fi...
Nvidia Owns These 4 Stocks. Here's How They're Doing.
Nvidia has been one of the best-performing stocks on Wall Street since 2023, amassing holdings in four companies along the way.
Nanox Launches Artificial Intelligence Functionality in Second Opinions Platform
Nanox integrates FDA-cleared population health AI solutions into its Second Opinions service
Nano-X Imaging Ltd. (NNOX) Q1 2024 Earnings Call Transcript
Nano-X Imaging Ltd. (NASDAQ:NNOX) Q1 2024 Earnings Conference Call May 28, 2024 8:30 AM ET Company Participants Mike Cavanaugh - Investor Relations Erez Meltzer - Chief Executive Officer Ran Daniel -...
Nanox Announces First Quarter of 2024 Financial Results and Provides Business Update
Accelerates Deployment of Nanox.ARC in United States Signed two commercial agreements for Nanox.AI Management to host conference call and webcast Tuesday, May 28, 2024 at 8:30 AM ET PETAH TIKVA, Isra...
Nanox to Report First Quarter and Financial Results on May 28, 2024
PETACH TIKVA, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will repor...
USARAD, Nanox's Teleradiology Subsidiary, Awarded Accreditation from The Joint Commission
Company earns Gold Seal of Approval® for Ambulatory Health Care Accreditation PETACH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an inn...
Nanox Files 2023 Annual Report on Form 20-F
PETACH TIKVA, Israel, April 22, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has file...
Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market
AhealthZ to aid Nanox's pursuit of local authorizations and licenses for Nanox.ARC in South Korea SCL Science to integrate Nanox's artificial intelligence solutions in operations PETAH TIKVA, Israel, ...
Nano-X Imaging Ltd. (NNOX) Q4 2023 Earnings Call Transcript
Nano-X Imaging Ltd. (NNOX) Q4 2023 Earnings Call Transcript
Nanox Announces Fourth Quarter of 2023 Financial Results and Provides Business Update
Nanox Launches Nanox.ARC in United States with Installations Across Five States, Marking a Major Advancement in Medical Imaging Management to host conference call and webcast Monday, April 1, 2024 at ...
Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
PETAH TIKVA, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced that it will rep...
Not just Soundhound, these AI stocks are also riding Nvidia wave
Following Nvidia's investment disclosure, SoundHound AI's shares have dramatically increased, tripling in value and boosting its market capitalization to $2.75 billion. The company's success is attrib...
Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold
– According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average
Nanox and Beilinson Hospital Announce Collaboration to Study Diagnostic Capabilities of Nanox.ARC for Detection of Lung and Chest Diseases
First patients in clinical study at Beilinson Hospital were scanned with the Nanox.ARC, a stationary X-ray system that produces 3D tomographic images